Radiobiological hypoxia in the KHT sarcoma: Predictions using the Eppendorf histograph

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 5, 1998, Pages 1171-1176

  Siemann, Dietmar W ^a   Johansen, Inger Marie ^b   Horsman, Michael R ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Blood flow modifiers; Eppendorf histograph; Gas breathing; Hemoglobin oxygen affinity modifiers; KHT sarcoma; Radiobiological hypoxia; Tumor oxygenation

Indexed keywords

HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CELL HYPOXIA; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; OXYGEN AFFINITY; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; RADIOBIOLOGY; RADIOSENSITIZATION; SARCOMA; TUMOR BLOOD FLOW;

EID: 0032521248     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00004-2     Document Type: Article

References (35)

1. Overgaard J., Horsman M. R. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and radiosensitizers. Semin. Radiat. Oncol. 6:1996;10-21.
2. Brizel D. M., Scully S. P., Harrelson J. M., Layfield L. J., Bean J. M., Prosnitz L. R., Dewhirst M. W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
3. Gatenby R. A., Kessler H. B., Rosenblaum J. S., Coia L. R., Moldofsky P. J., Hartz W. H., Broder G. J. Oxygen distribution in squamous cell carcinoma metastases and its relatonship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;831-838.
4. Hoeckel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
5. Kolstad P. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand. J. Clin. Lab. Invest. 106:1968;145-157.
6. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinioma of the head and neck. Radiother. Oncol. 41:1996;31-39.
7. Horsman M. R. Hypoxia in tumours Its relevance, identification and modification . Beck-Bornholdt H. P. Current topics in clinical radiobiology of tumors. 1993;99-112 Springer Verlag, Berlin.
8. Raleigh J. A., Dewhirst M. W., Thrall D. E. Measuring tumor hypoxia. Semin. Radiat. Oncol. 6:1996;37-45.
9. Stone H. B., Brown J. M., Phillips T. L., Sutherland R. M. Oxygen in human tumors Correlations between methods of measurement and response to therapy . Radiat. Res. 136:1993;422-434.
10. Horsman M. R., Khalil A. A., Nordsmark M., Grau C., Overgaard J. Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model. Radiother. Oncol. 28:1993;69-71.
11. Kallman R. F., Silini G., Van Putten L. M. Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors. J. Natl. Cancer Inst. 39:1967;539-549.
12. Thomson J. E., Rauth A. M. An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions. Radiat. Res. 58:1974;262-276.
13. 2) on the in vivo radiation response of a murine sarcoma . Int. J. Radiat. Oncol. Biol. Phys. 2:1977;903-911.
14. Siemann D. W., Allalunis-Turner M. J. Potentiation of combination chemotherapy by nitroheterocyclics. Int. J. Radiat. Oncol. Biol. Phys. 15:1988;129-134.
15. 2-histography. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;953-961.
16. Chaplin D. J., Acker B. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069 Evidence for therapeutic gain . Int. J. Radiat. Oncol. Biol. Phys. 13:1987;579-585.
17. Horsman M. R., Christensen L., Overgaard J. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. Int. J. Hyperthermia. 5:1990;123-136.
18. Siemann D. W. Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine. Br. J. Cancer. 62:1990;348-353.
19. Siemann D. W., Hill R. P., Bush R. S. Smoking The influence of carboxyhemoglobin (HbCO) on tumor oxygenation and response to radiation . Int. J. Radiat. Oncol. Biol. Phys. 4:1978;657-662.
20. Grau C., Horsman M. R., Overgaard J. Influence of carboxyhemoglobin level on tumor growth, blood flow and radiation response in an experimental model. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;421-424.
21. Hirst D. G., Wood P. J., Schwartz H. C. The modification of hemoglobin affinity for oxygen and tumor radiosensitization by antilipidemic drugs. Radiat. Res. 112:1987;164-172.
22. Siemann D. W., Alliet K. L., Macler L. M. Manipulations in the oxygen transport capacity of blood as a means of sensitizing tumors to radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 15:1989;1169-1172.
23. Chaplin D. J., Horsman M. R., Siemann D. W. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo Importance of nicotinamide dose and preirradiation breathing time . Br. J. Cancer. 68:1993;269-273.
24. Grau C., Horsman M. R., Overgaard J. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;415-419.
25. Inch W. R., McCredie J. A., Sutherland R. M. Effect of duration of breathing 95% oxygen plus 5% carbon dioxide before x-irradiation on cure of C3H mammary tumor. Cancer. 25:1970;926-931.
26. Rojas A. Radiosensitization with normobaric oxygen and carbogen. Radioth. Oncol. 20:1991;65-70.
27. Suit H. D., Marshall N., Woerner D. Oxygen, oxygen plus carbon dioxide, and radiation therapy of a mouse mammary carcinoma. Cancer. 30:1972;1154-1158.
28. 2 by perfluorochemicals and carbogen. Int. J. Radiat. Oncol. Biol. Phys. 13:5691987.
29. Horsman M. R., Nordsmark M., Khalil A. A., Hill S. A., Chaplin D. J., Siemann D. W., Overgaard J. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing. Acta Oncol. 33:1994;371-376.
30. Rojas A., Joiner M. C., Hodgkiss R. J., Carl U., Kjellen E., Wilson G. D. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen A therapeutic comparison with skin and kidneys . Int. J. Radiat. Oncol. Biol. Phys. 23:1992;361-366.
31. Siemann D. W., Hill R. P., Bush R. S., Chhabra P. The in vivo radiation response of an experimental tumor The effect of exposing tumor-bearing mice to a reduced oxygen environment prior to but not during radiation . Int. J. Radiat. Oncol. Biol. Phys. 5:1979;61-68.
32. Thomas C. D., Prade M., Guichard M. Tumour oxygenation, radiosensitivity, and necrosis before and/or after nicotinamide, carbogen and perflubron emulsion administration. Int. J. Radiat. Biol. 67:1995;597-605.
33. Sasai K., Brown J. M. Discrepancies between measured changes of radiobiological hypoxic fraction and oxygen tension monitoring using two assay systems. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;355-361.
34. Horsman M. R., Khalil A. A., Siemann D. W., Grau C., Hill S. A., Lynch E. M., Chaplin D. J., Overgaard J. Relationship between radiobiological hypoxia in tumors and electrode measurement of tumor oxygenation. Int. J. Radiat. Oncol. Biol. Phys. 29:1994;439-442.
35. 3H] misonidazole binding and paired survival assay . Radiat. Res. 145:1996;491-500.